Accelerate Diagnostics | AXDX - Cost Of Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Accelerate Diagnostics

Accelerate Diagnostics reported $1.8M in Cost of Sales for its fiscal quarter ending in March of 2023.


Cost Of Sales Change
Abbott ABT:US USD 4.32B 209M
Accelerate Diagnostics AXDX:US USD 1.8M 330K
Becton, Dickinson and Co. BDX:US USD 2.59B 133M
Bio-Rad Laboratories BIO:US USD 314.43M 22.06M
Bruker BRKR:US USD 325.6M 17.2M
Danaher DHR:US USD 2.8B 633M
Exact Sciences EXAS:US USD 156.87M 9.71M
Hologic HOLX:US USD 440.7M 15.6M
Illumina ILMN:US USD 432M 21M
Myriad Genetics MYGN:US USD 59.2M 5.3M
NanoString Technologies NSTG:US USD 22.87M 1.75M
Pacific Biosciences Of California PACB:US USD 29.14M 10.63M
PerkinElmer PKI:US USD 293.5M 11.38M
Quidel QDEL:US USD 397.5M 20M
Thermo Fisher Scientific TMO:US USD 6.44B 278M